华康生物医学(08622)公布1月月报表,股本维持稳定

公告速递
Feb 03

华康生物医学控股有限公司(08622)于2026年2月3日公布截至2026年1月31日的股份变动月报表。公告显示,公司法定股本及已发行股份在报告期内均未发生变动。

公司披露,截至1月底,法定/注册股本维持在10,000,000港元,对应1,000,000,000股,面值每股0.01港元。已发行股本方面,普通股数量继续为515,472,000股,未有新增发行或库藏股变动。

本月未涉及任何股份期权、购回或注销安排,截至报告期末公司整体股本保持稳定。公司声明已遵循香港联合交易所有限公司《上市规则》及相关法律法规的要求。公告由公司秘书周丽麒签署。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10